Ipswich Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ipswich Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-250	Closed	-$24K	–	428
2018 Q4	$24K	Buy	+250	New	+$32.8K	0.01%	320
2016 Q2	–	Sell	-50	Closed	-$4K	–	352
2016 Q1	$4K	Buy	+50	New	+$2.74K	﹤0.01%	363

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ipswich Investment Management's GWPH Position: Q1 2019 in Review

Ipswich Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2019, closing a stake of 250 shares — an estimated $24K sold.

Ipswich Investment Management first reported a position in GWPH in Q1 2016 and held it in 2 quarters. The position peaked at $24K in Q4 2018. 320 funds tracked by Wall St. Rank hold GWPH as of Q1 2019.

Ipswich Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
Ipswich Investment Management sold 250 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2019, an estimated $24K.
Ipswich Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 2 quarters.
Ipswich Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $24K in Q4 2018.
320 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2019.

Based on Ipswich Investment Management's 13F filing for Q1 2019, filed 12 Apr 2019.